Prediction of esophageal varices and risk of bleeding in liver cirrhosis by aspartate aminotransferase to-platelet ratio index and fibrosis-4 index
DOI:
https://doi.org/10.18203/2349-3933.ijam20231073Keywords:
Liver cirrhosis, CLD, APRI, FIB-4, CTP, UGIEAbstract
Background: Liver cirrhosis is the end-stage for chronic liver disease. During the course of cirrhosis repeated endoscopy is recommended. As this intervention is expensive and often poorly accepted by patients who may refuse further follow up, there is a need for non-invasive methods to predicts the progression of portal hypertension as well as the presence and size of esophageal varices. This study was aimed to assess the value of aspartate aminotransferase (AST)-to-platelet ratio index (APRI) and fibrosis-4 index (FIB-4) for predicting esophageal varices in cirrhotic patients. Objectives of the study were: prediction of esophageal varices and risk of bleeding in liver cirrhosis by APRI, and prediction of esophageal varices and risk of bleeding in liver cirrhosis by FIB-4.
Methods: It was a single centre, observational study in 100 patients of chronic liver disease. Patients were included in the study after applying inclusion and exclusion criteria. Complete blood count (CBC), liver function test (LFT), kidney function test (KFT), SE, viral marker, ultrasonography (USG) whole abdomen, and upper gastrointestinal endoscopy (UGIE) was done for all patients. Child-Pugh-Turcotte (CTP) score was calculated for every patient.
Results: The APRI and FIB-4 shows moderate diagnostic accuracy in predicting the presence of esophageal varices and variceal bleed.
Conclusions: In conclusion, the APRI and FIB-4 shows moderate diagnostic accuracy in predicting the presence of esophageal varices and variceal bleed. They help in starting prophylactic therapy earlier to prevent the bleeding and other complications of varices. Although endoscopy remains the primary modality for diagnosis of esophageal varices but these non-invasive parameters can also play an effective role in conjunction with endoscopy in predicting the presence of esophageal varices.
References
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980- 2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018;392(10159):1736-88.
D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44(1):217-31.
Biecker E. Portal hypertension and gastrointestinal bleeding: diagnosis, prevention and management. World J Gastroenterol. 2013;19(31):5035-50.
Groszmann RJ, Garcia-Tsao G, Bosch J, et al. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med. 2005;353(21):2254-61.
Par G, Trosits A, Pakidi F, Szabo I, Czimer J. Transient elastography as a predictor of esophageal varices in patients with liver cirrhosis. J Orv Hetil 2014;155(7):270-6.
Tempesta D, Fattovich G, Laurent C, Halfon P. Prediction of esophageal varices in hepatic cirrhosis by simple non-invasive markers: Results of a multicenter, large scale study. J Hepatol. 2010;53:630-8.
Deng H, Qi X, Peng Y. Diagnostic Accuracy of APRI, AAR, FIB-4, FI, and King Scores for Diagnosis of Esophageal Varices in Liver Cirrhosis: A Retrospective Study. Med Sci Monit. 2015;21:3961-77.
Hassan EA, El-Rehim ASEA, Sayed ZEA, Ashmawy AM, Kholef EFM, Sabry A, et al. Noninvasive Fibrosis Scores as Prognostic Markers for Varices Needing Treatment in Advanced Compensated Liver Cirrhosis. Open J Gastroenterol. 2017;7:230-42.
Morishita N, Hiramatsu N, Oze T, Harada N, Yamada R, Miyazaki M, et al. Liver stiffness measurement by acoustic radiation force impulse is useful in predicting the presence of esophageal varices or highrisk esophageal varices among patients with HCV-related cirrhosis. J Gastroenterol. 2014;49(7):1175-82.
Sebastiani G, Tempesta D, Fattovich G, Laurent C, Halfon P. Prediction of esophageal varices in hepatic cirrhosis by simple non-invasive markers: Results of a multicenter, large scale study. J Hepatol. 2010 ;53:630-8.
Baig, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38(2):518-26.
Sarangapani A, Shanmugam C, Kalyanasundaram M, Rangachari B, Thangavelu P, Subbarayan JK. Non-invasive prediction of large esophageal varices in chronic liver disease patients. Saudi J Gastroenterol. 2010;16(1):38-42.
Khuram M, Stefanescu H, Grigorescu M, Lupsor M. A new and simple algorithm for the noninvasive assessment of esophageal varices in cirrhotic patients using serum fibrosis markers and transient elastography. J Gastrointestin Liver Dis. 2011;20(1):57-64.
Zaman A, Flamm SL, Gordon FD, Chopra S. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol. 1998;93(1):44-8.
Castera L, Vergniol J, Fouchar J, Le Bail B, Chanteloup E, Haaser M, et al. Prospective comparison of ransientelastography, fibrotest, APRI and liver biopsy for assessment of fibrosis in chronic hepatitis C. Gastroenterology. 2013;128:343-50.
Tafarel JR, Tolentino LH, Correa LM, Bonita DR, Matin FS. Prediction of esophageal varices in hepatic cirrhosis by noninvasive markers. Eur J Gastroenterol Hepatol. 2011;23:754-8.
Wang JH, Cruah SK, Lu SN, Hung CH, Chen CH. Transient elastography and simple blood markers in the diagnosis of esophageal varices for compensated patients with hepatitis B virus related cirrhosis. J Gastroenterol Hepatol. 2012;27:1213-8.
Shah VH, Kamath. Portal hypertension and variceal bleeding. In: Feldman M, Friedman LS & Brandt LJ (eds). Sleisenger and Fordtrans Gastrointestinal and Liver Disease. 10th ed. Philadelpia, Elsevier. 2016.
